Acumen Pharmaceuticals, Inc.
ABOS • NASDAQ
Acumen Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Daniel J. O'Connell, with a market cap of $163.2M.
CEODaniel J. O'Connell
Next Earnings
Upcoming earnings announcement for Acumen Pharmaceuticals, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Earnings History
Past 12 earnings reports for Acumen Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.41Est: -$0.53 | +22.6% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.44Est: -$0.66 | +33.3% | - | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.68Est: -$0.53 | -28.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.48Est: -$0.55 | +12.7% | - | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | -$0.62Est: -$0.37 | -67.6% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.50Est: -$0.36 | -38.9% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.34Est: -$0.28 | -21.4% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.25Est: -$0.26 | +3.8% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.29Est: -$0.26 | -11.5% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.24Est: -$0.27 | +11.1% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.28Est: -$0.36 | +22.2% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.28Est: -$0.35 | +20.0% | - | — | — |